The Biden-Harris Administration’s Statement Of Drug Policy Priorities For Year One

On April 1, 2021, the "Biden-Harris Administration" released this statement of drug policy priorities for year one of their presidency. The agenda includes seven main areas on which the administration says it will focus during its first year in office. Those priorities include increasing access to evidence-based SUD treatment, particularly for buprenorphine medication-assisted treatment (MAT); better enforcing behavioral health parity; improving racial equity; and enhancing harm-reduction efforts, in addition to other priorities . . .